Combination Oral Chelation in Adult Patients With Transfusion-dependent Thalassemia and High Iron Burden

被引：9
|
作者：
Hammond, John [1 ]
Thompson, Alexis A. [4 ,5 ]
Fogel, Mark A. [2 ]
Hammond, Katherine [4 ]
Kokroko, Jolene [1 ]
Kwiatkowski, Janet L. [1 ,3 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Cardiol, 34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2019年 / 41卷 / 01期
关键词：
thalassemia; iron overload; deferasirox; deferiprone; MYOCARDIAL IRON; DEFERIPRONE THERAPY; DEFERASIROX; SAFETY; DEFEROXAMINE; TRIAL; RISK;
D O I：
10.1097/MPH.0000000000001269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
An open-label, pilot study was conducted to evaluate deferasirox/deferiprone combination chelation therapy in adult patients with transfusion-dependent thalassemia and severe iron overload. Enrollment proved difficult. Nine patients (median age, 27.4 y; ferritin, 4965 ng/mL; liver iron concentration, 28.5 mg/g dry weight; cardiac T2*, 13.3 ms) received treatment. Two were withdrawn for treatment-related adverse effects. Arthralgia (4 patients) and gastrointestinal symptoms (5 patients) were common; no episodes of neutropenia/agranulocytosis occurred. Adherence difficulties were common. Of 6 patients with 12 to 18 months follow-up, 3 showed improvement in cardiac T2* and 2 in liver iron. Combination oral chelation may be effective but adverse effects and adherence challenges may limit efficacy.
引用
收藏
页码：E47 / E50
页数：4
相关论文
共 50 条
  • [1] IRON CHELATION IN TRANSFUSION-DEPENDENT THALASSEMIA WITH CHRONIC HEPATITIS
    DEVIRGILIIS, S
    COSSU, P
    SANNA, G
    FRAU, F
    LOI, E
    LOBRANO, R
    NUCARO, A
    TOCCAFONDI, C
    CORNACCHIA, G
    LOI, A
    CAO, A
    ACTA HAEMATOLOGICA, 1982, 67 (01) : 49 - 56
  • [2] EFFECT OF CHELATION ON CARDIAC IRON OVERLOAD IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA
    Pines, Morgan
    Sheth, Sujit
    Kleinert, Dorothy
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [3] Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
    Origa, Raffaella
    Cinus, Monia
    Pilia, Maria Paola
    Gianesin, Barbara
    Zappu, Antonietta
    Orecchia, Valeria
    Clemente, Maria Grazia
    Pitturru, Carla
    Denotti, Anna Rita
    Corongiu, Francesco
    Piras, Simona
    Barella, Susanna
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [4] Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia
    Jamuar, Saumya S.
    Lai, Angeline H. M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 299 - 307
  • [5] A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients
    Theppornpitak, Krisada
    Trakarnsanga, Bussaba
    Lauhasurayotin, Supanun
    Poparn, Hansamon
    Chiengthong, Kanhatai
    Sosothikul, Darintr
    Techavichit, Piti
    HEMOGLOBIN, 2021, 45 (03) : 171 - 174
  • [6] Practice of iron chelation therapy for transfusion-dependent thalassemia in Southeast Asia
    Azman, Nurul Fatihah
    Abdullah, Wan-Zaidah
    Mohamad, Norsarwany
    Bahar, Rosnah
    Johan, Muhammad Farid
    Diana, R.
    Sarifah, Binti Hanafi
    Yusoff, Surini
    Nasir, Ariffin
    Othman, Azizah
    Sukeri, Surianti
    Ibrahim, Mohd Ismail
    Hussein, Adil
    Hassan, Rozita
    Yahya, Padillah
    Hassan, Rosline
    Zilfalil, Bin Alwi
    ASIAN BIOMEDICINE, 2016, 10 (06) : 537 - 547
  • [7] Effect of different iron chelation regimens on bone mass in transfusion-dependent thalassemia patients
    Bordbar, Mohammadreza
    Haghpanah, Sezaneh
    Zekavat, Omid Reza
    Saki, Forough
    Bazrafshan, Asghar
    Bozorgi, Haleh
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (11) : 997 - 1003
  • [8] Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
    Saliba, Antoine N.
    Harb, Afif R.
    Taher, Ali T.
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 197 - 209
  • [9] Current recommendations for chelation for transfusion-dependent thalassemia
    Kwiatkowski, Janet L.
    COOLEY'S ANEMIA, 2016, 1368 : 107 - 114
  • [10] Clinical and Economic Burden of Transfusion-Dependent ß-Thalassemia in Adult Patients in the United States
    Sheth, Sujit
    Weiss, Mia
    Parisi, Monika
    Ni, Quanhong
    BLOOD, 2017, 130
12345